Bester L - Search Results

1

Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.

Bester L, Feitelson S, Milner B, Chua TC, Morris DL. Bester L, et al. Am J Clin Oncol. 2014 Oct;37(5):454-60. doi: 10.1097/COC.0b013e31827deea1. Am J Clin Oncol. 2014. PMID: 23388564

2

Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization.

Bester L, Salem R. Bester L, et al. J Vasc Interv Radiol. 2007 Oct;18(10):1310-4. doi: 10.1016/j.jvir.2007.07.003. J Vasc Interv Radiol. 2007. PMID: 17911524

3

Anterior abdominal wall uptake in intrahepatic arterial brachytherapy with yttrium-90 sir spheres for hepatic malignancy.

Chernyak I, Bester L, Freund J, Richardson M. Chernyak I, et al. Among authors: bester l. Clin Nucl Med. 2008 Oct;33(10):677-80. doi: 10.1097/RLU.0b013e318184b44f. Clin Nucl Med. 2008. PMID: 18806566

4

Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.

Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Saxena A, et al. Among authors: bester l. Ann Surg Oncol. 2010 Feb;17(2):484-91. doi: 10.1245/s10434-009-0777-x. Epub 2009 Oct 30. Ann Surg Oncol. 2010. PMID: 19876691

5

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.

Cao CQ, Yan TD, Bester L, Liauw W, Morris DL. Cao CQ, et al. Among authors: bester l. Br J Surg. 2010 Apr;97(4):537-43. doi: 10.1002/bjs.6931. Br J Surg. 2010. PMID: 20205229

6

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.

Saxena A, Chua TC, Bester L, Kokandi A, Morris DL. Saxena A, et al. Among authors: bester l. Ann Surg. 2010 May;251(5):910-6. doi: 10.1097/SLA.0b013e3181d3d24a. Ann Surg. 2010. PMID: 20395859

7

Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer.

Wang SC, Bester L, Burnes JP, Clouston JE, Hugh TJ, Little AF, Padbury RT, Price D. Wang SC, et al. Among authors: bester l. J Med Imaging Radiat Oncol. 2010 Jun;54(3):178-87. doi: 10.1111/j.1754-9485.2010.02167.x. J Med Imaging Radiat Oncol. 2010. PMID: 20598004 Review.

8

Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.

Chua TC, Bester L, Akther J, Morris DL. Chua TC, et al. Among authors: bester l. Anticancer Res. 2010 Jul;30(7):3005-7. Anticancer Res. 2010. PMID: 20683046

9

Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.

Evans KA, Richardson MG, Pavlakis N, Morris DL, Liauw W, Bester L. Evans KA, et al. Among authors: bester l. J Vasc Interv Radiol. 2010 Oct;21(10):1521-6. doi: 10.1016/j.jvir.2010.06.018. Epub 2010 Sep 1. J Vasc Interv Radiol. 2010. PMID: 20813542

10

Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases.

Chua TC, Bester L, Saxena A, Morris DL. Chua TC, et al. Among authors: bester l. J Cancer Res Clin Oncol. 2011 May;137(5):865-73. doi: 10.1007/s00432-010-0948-y. Epub 2010 Sep 22. J Cancer Res Clin Oncol. 2011. PMID: 20859640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters